©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 28, 2014; 20(20): 6170-6179
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6170
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6170
Table 2 Summary of council of europe and organ procurement and transplantation network/united network for organ sharing guidelines for donor with cancer history
| Council of Europe guidelines[17]: Donors with unacceptable risk of transmission | |
| Features applicable to cancer of any histological type at any time prior to donation | |
| Presence of metastasis - lymphatic or distant | |
| Absence of curative surgical treatment or missed follow-up (except low-grade prostate cancer under surveillance) | |
| Palliative therapy for cancer | |
| Non-CNS cancer at any time prior to donation | |
| Breast | |
| Ovary | |
| Choriocarcinoma | |
| Malignant melanoma, including carcinoma-in-situ | |
| Sarcoma | |
| Chronic Leukaemia | |
| Thyroid (except capsulated papillary or minimally invasive follicular type) | |
| Non-CNS cancer diagnosed during donor procurement | |
| All cancers, except: | |
| Renal cell cancer < 2.5-4.0 cm (pT1a), tumour free resection margin and Fuhrman grade I or II | |
| Localised low grade (Gleason score ≤ 6) prostate cancer | |
| Small gastrointestinal stromal tumours | |
| Localised non-melanoma skin cancer | |
| Cancers of the CNS | |
| WHO grade IV cancers | |
| WHO grade III cancers with following features: | |
| Presence of ventriculo-peritoneal or ventriculo-atrial shunts | |
| Craniotomy | |
| Systemic chemotherapy | |
| Radiotherapy | |
| OPTN/UNOS guidelines[18] - intermediate or high risk of transmission | |
| Intermediate risk of transmission (1%-10%) Breast cancer, stage 0 Colon cancer, stage 0 Renal cell cancer (resected, solitary): 4-7 cm, well differentiated, stage I Treated non-CNS malignancy (≥ 5 yr prior) with cure rate 90%-99% | High risk of transmission (> 10%) Breast cancer, stage > 0 Colon cancer, stage > 0 Renal cell cancer: > 7 cm or stage II-IV Choriocarcinoma Leukaemia Lymphoma Small cell cancer: lung/neuroendocrine Metastatic carcinoma Sarcoma Lung cancer: stage I-IV Any CNS tumour with ventriculo-peritoneal or ventriculo-atrial shunt, surgery (other than uncomplicated biopsy), irradiation or extra-cranial metastases CNS tumour of WHO grade III or IV Any other cancer with insufficient follow-up or probability of cure < 90% |
-
Citation: Desai R, Neuberger J. Donor transmitted and
de novo cancer after liver transplantation. World J Gastroenterol 2014; 20(20): 6170-6179 - URL: https://www.wjgnet.com/1007-9327/full/v20/i20/6170.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i20.6170